Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$10,461,786
+$771,452 QoQ
Shares Held
41,193
+3.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.73%
of 13F equity value
Holder Rank
#1,084
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $43,360,679 across 8 Drug Manufacturers - General names. JNJ ranks #2 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,858 | $13,023,412 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
41,193 | $10,461,786 | |
| 3 | ABBV |
AbbVie Inc.
|
32,676 | $8,222,588 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,241 | $5,556,468 | |
| 5 | AMGN |
Amgen Inc
|
12,997 | $4,706,473 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,426 | $715,986 | |
| 7 | PFE |
Pfizer Inc
|
17,043 | $410,395 | |
| 8 | AZN |
Astrazeneca PLC
|
1,390 | $263,571 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,461,786 | 41,193 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $9,690,334 | 39,643 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $9,068,342 | 43,819 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $7,759,456 | 41,848 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $6,242,587 | 40,868 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,681,030 | 40,286 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $5,602,289 | 38,738 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,170,272 | 38,074 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $5,377,518 | 36,792 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $5,637,100 | 35,635 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $5,493,737 | 35,050 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $5,142,397 | 33,017 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $5,374,599 | 32,471 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,903,115 | 31,633 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,588,146 | 31,634 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $4,847,871 | 29,676 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $4,727,801 | 26,634 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,092,949 | 23,094 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,575,876 | 20,903 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,331,745 | 20,630 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,258,557 | 19,780 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $3,012,371 | 18,329 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,853,456 | 18,131 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,647,830 | 17,785 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,527,121 | 17,970 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $2,299,889 | 17,539 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||